Analysts expect over 2021 decreasing revenue Biogen

Tomorrow the American Biogen will report its past quarters results. For this year Biogen 's (located in Cambridge) revenue will be around 10.77 billion USD. This is according to the average of the analysts' estimates. This is rather significant lower than 2021's revenue of 13.44 billion USD.

Historical revenues and results Biogen plus estimates 2021

The analysts expect for 2021 a net profit of 2.81 billion USD. The majority of the analysts expects for this year a profit per share of 18.63 USD. Based on this the price/earnings-ratio is 15.09.

Analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a relatively high 2.64 percent.

Latest estimates around 272 USD

The most recent recommendations for the biotech company are from DZ Bank, KBC Securities and ABN AMRO .

Biogen 's market capitalization is around 48.98 billion USD. 0

On Friday the stock closed at 281.19 USD.

Historical stock prices Biogen

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.